May 16, 2018 / 10:36 AM / 9 days ago

BRIEF-Hls Therapeutics Announces Qtrly Net Loss $0.19 Per Common Share

May 16 (Reuters) - HLS Therapeutics Inc:

* Q1 REVENUE $13.2 MILLION VERSUS $15.6 MILLION

* QTRLY NET LOSS $0.19 PER COMMON SHARE Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below